mHSPC/mCSPC

Early Discontinuation of Upfront ARSIs Without Disease Progression in Patients With mCSPC
A recent study evaluated the impact of early withdrawal of upfront ARSIs on clinical outcomes in patients with mCSPC.
Advertisement

Roundtable Discussions

Prostate Cancer Knowledge Hubs

Prostate Cancer
Prostate Cancer
Advertisement
Section Editor

Advertisement
Get the latest mHSPC research straight to your inbox.